Insight Molecular Diagnostics Inc. (NAS: IMDX) Stock Analysis & Fundamentals | ScreenerHero

Create free account

IMDXInsight Molecular Diagnostics Inc.

NAS · US · Healthcare · Diagnostics & Research · imdxinc.com

5.900USD+8.86%Mkt Cap: 190.51M $P/E: —1d ago

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests,…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

1M Perf

Higher

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap190.51M $

Enterprise Value165.38M $

Revenue (TTM)1.95M $

Gross Profit2.30M $

Net Income (TTM)-50.22M $

Revenue/Share0.0600 USD

Last Price5.900 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees55

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-7.56

PEG—

EV/EBITDA-5.07

EV/Revenue84.85

P/S97.75

P/B-17.82

EPS (TTM)-1.51

EPS (Forward)-0.78

52W Range

2.33058% of range8.510

52W High8.510 USD

52W Low2.330 USD

Profitability

Gross Margin56.67%

Oper. Margin-32275.00%

EBITDA Margin0.00%

Profit Margin-1238.52%

ROE159.62%

ROA-194.99%

Growth

Revenue Growth-98.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-22.18M $

CapEx (TTM)3.19M $

FCF Margin-803.47%

FCF Yield-8.22%

Net Debt-25.13M $

Net Debt/EBITDA0.77

Balance Sheet

Debt/Equity-0.11

Current Ratio2.54

Quick Ratio2.36

Book Value/Sh-0.3310 USD

Cash/Share0.8730 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateJul 25, 2023

Analyst Consensus

Rating—

Target (Mean)8.333 USD

Upside (mean)+41.2%

Target Range4.000 USD – 12.00 USD

$4.000+41.2% to mean$12.00

# Analysts3

Ownership

Shares Out.32.29M

Float9.97M

Insiders21.43%

Institutions60.98%

Short Interest

Short Ratio3.8d

Short % Float7.24%

Short % Out.3.55%

Shares Short1.15M

Short (prev mo.)1.18M

Technical

SMA 505.269 (+12.0%)

SMA 2005.305 (+11.2%)

Beta1.77

S&P 52W Chg20.05%

Avg Vol (30d)262.90K

Avg Vol (10d)247.40K

Technical Indicators

RSI (14)55.7

MACD0.0090

MACD Signal0.0299

MACD Hist.-0.0209

BB Upper6.271 USD

BB Middle5.622 USD

BB Lower4.973 USD

BB Width23.10%

ATR (14)0.5952 USD

Vol Ratio (20d)0.66x